Evolving portal hypertension through Baveno VII recommendations
Open Access
- 19 November 2023
- journal article
- research article
- Published by Elsevier in Annals of Hepatology
- Vol. 29 (1) , 101180
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” studyHepatology, 2016
- Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertensionJournal of Hepatology, 2016
- Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosisAlimentary Pharmacology & Therapeutics, 2016
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patientsAlimentary Pharmacology & Therapeutics, 2014
- A MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal BleedingGastroenterology, 2014
- Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololGut, 2012
- Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced CirrhosisGastroenterology, 2012
- Prognostic indicators of survival in patients with compensated and decompensated cirrhosisLiver International, 2012
- Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosisHepatology, 2002